Thursday, May 16, 2013

• Cyclacel Pharmaceuticals Announces $20 Million Underwritten OfferingGlobeNewswire( (Thu, May 16)

Wednesday, May 15, 2013

• Cyclacel Pharmaceuticals Announces Proposed Public Offering of Common StockGlobeNewswire( (Wed, May 15)

Monday, May 13, 2013

• Cyclacel Reports First Quarter 2013 Financial ResultsGlobeNewswire( (Mon, May 13)

Friday, May 10, 2013

• Cyclacel Pharmaceuticals to Announce Release of First Quarter 2013 Financial ResultsGlobeNewswire( (Fri, May 10)

Tuesday, April 30, 2013

• Cyclacel Reports Updated Phase 2 Survival Data of Sapacitabine for MDSGlobeNewswire( (Tue, Apr 30)

Tuesday, April 23, 2013

• Cyclacel Pharmaceuticals to Present at the 12th Annual Needham Healthcare ConferenceGlobeNewswire( (Tue, Apr 23)

Tuesday, April 9, 2013

• Combination Potential of Cyclacel's Sapacitabine and Seliciclib Reported at AACRGlobeNewswire( (Tue, Apr 9)

Monday, April 8, 2013

• AACR Press Conference Highlights Combination Potential of Two Cyclacel DrugsGlobeNewswire( (Mon, Apr 8)

Thursday, April 4, 2013

• Cyclacel Announces Sale of Four Cyclacel Romidepsin-Related Patents to Celgene and Dismissal of All Claims in Their Patent LitigationGlobeNewswire( (Thu, Apr 4)

Wednesday, April 3, 2013

• Cyclacel Announces Multiple Abstracts Selected for Presentation at American Association for Cancer Research Annual MeetingGlobeNewswire( (Wed, Apr 3)

Wednesday, March 27, 2013

• Cyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2012 Financial ResultsGlobeNewswire( (Wed, Mar 27)

Friday, March 22, 2013

• Cyclacel to Announce Year-End and Fourth Quarter 2012 Financial ResultsGlobeNewswire( (Fri, Mar 22)